Answers are grounded in this paper and cite their sources.
The majority of patients with Hodgkin's disease can be cured with current treatment modalities. Relapses beyond 3 years are rare; however, the outcome for patients in late relapse with standard-dose salvage therapy is excellent. In this article, we report five patients who had such relapses and describe their outcome.
No takes yet. Share an insight, caveat, or question.
Shihabi et al. (2001) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: